Therapy that includes basal insulin is a cornerstone of management of patients with type 2 diabetes (T2DM). Despite its benefits, use of basal insulin too often is overlooked or delayed due to clinical inertia or patient objections and fears. This eCase explores issues surrounding initiation of basal insulin therapy, including addressing patient objections, educating patients about injections and hypoglycemia, and choosing an appropriate basal insulin for each patient.
Case study with interactive benchmarking
To improve long-term outcomes for patients with T2DM through appropriate use of basal insulin therapy, increase clinician understanding of patient objections and other issues that limit basal insulin use, and minimize clinical inertia in primary care management.
After completing this activity, participants should be better able to:
- Implement strategies to achieve glycemic goals based on current guidelines and individual patient factors
- Use guidelines to integrate basal insulin therapy, as appropriate, into the treatment plans of patients with T2DM
- Describe the differences and similarities between various basal insulin formulations
Nurse practitioners and physician assistants
In support of improving patient care, Continuing Education Alliance is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Nursing contact hours: 0.50, which includes 0.50 hours of pharmacology credit.
This program has been reviewed and is approved for a maximum of 0.50 of AAPA Category 1 CME credits by the AAPA Review Panel. Approval is valid for one year from the issue date of May 3, 2017. Participants may submit the post-test at any time during that period.
This program was planned in accordance with AAPA CME Standards for Enduring Material Programs and for Commercial Support of Enduring Material Programs.
This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC.
The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Continuing Education Alliance, Practicing Clinicians Exchange, the AAPA, Boehringer Ingelheim, or Lilly.
All faculty and planners participating in continuing education activities sponsored by Continuing Education Alliance are expected to disclose to the audience any significant support or substantial relationship(s) with providers of commercial products and/or devices discussed in this activity and/or with any commercial supporters of the activity. In addition, all faculty are expected to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and planning committee have been advised that this activity must be free from commercial bias, and based upon all the available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Ms Kruger: advisory board: Abbott, Dexcom, Janssen, Lilly, Novo Nordisk, Sanofi; speakers bureau: Abbott, AstraZeneca, Boehringer Ingelheim, Dexcom, Lilly, Novo Nordisk, Valeritas; grant/research support (to Henry Ford Health System): AstraZeneca, Dexcom, Helmsley Foundation, Lexicon, Lilly, Novo Nordisk; stock: Dexcom.
The Planning Committee for this activity included Ruth Cohen and Leslie Burgess of Continuing Education Alliance; and Mark Christiansen, PhD, PA-C, of the University of the Pacific. The members of the Planning Committee have no significant relationships to disclose.
Participants wishing to earn CE/CME credit must:
- Read the eCase in its entirety
- Relate the content material to the learning objectives
- Complete the post-test and evaluation form online
Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of at least 66%.
The estimated time to complete this activity is 0.50 hours.
Release date: May 3, 2017
Expiration date: May 3, 2018
© 2018 Practicing Clinicians Exchange. All Rights Reserved. BIPCE91917